Fate Therapeutics, Inc. (FATE)

1.55 -0.07 (-4.32%) USD  |  NASDAQ  |  Feb 25, 14:04
More

Fate Therapeutics Beginning Cash (Quarterly)

Beginning Cash (Quarterly) Chart

View Beginning Cash (Quarterly) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Beginning Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Beginning Cash (Quarterly) Range, Past 5 Years

View Beginning Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Beginning Cash (Quarterly) Benchmarks

View Beginning Cash (Quarterly) Benchmarks
Start Trial
MannKind Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Ardelyx, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade